Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATM | Q13315 | 2/20 | 0.68 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.67 |
| ▸ | THRB | P10828 | 1/20 | 0.67 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.67 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.67 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.67 |
| ▸ | TACR1 | P25103 | 1/20 | 0.66 |
| ▸ | POLB | P06746 | 1/20 | 0.65 |
| ▸ | LMNA | P02545 | 1/20 | 0.62 |
| ▸ | GLA | P06280 | 1/20 | 0.62 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.60 |
| ▸ | CTSS | P25774 | 1/20 | 0.60 |
| ▸ | CTSK | P43235 | 1/20 | 0.60 |
| ▸ | PAM | P19021 | 1/20 | 0.60 |
| ▸ | GAA | P10253 | 1/20 | 0.59 |
| ▸ | RAB9A | P51151 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1884230 | 1.00 | ATM (0.68) | ATMALDH1A1THRBCYP2C9CYP2C19 | |
| SCHEMBL803579 | 1.00 | ATM (0.68) | ATMALDH1A1THRBCYP2C9CYP2C19 | |
| SCHEMBL3734223 | 0.94 | ALDH1A1 (0.68) | ATMALDH1A1THRBCYP2C9CYP2C19 | |
| SCHEMBL27488362 | 0.94 | ALDH1A1 (0.68) | ATMALDH1A1THRBCYP2C9CYP2C19 | |
| SCHEMBL16523532 | 0.92 | HDAC1 (0.64) | ATMALDH1A1THRBCYP2C9CYP2C19 | |
| SCHEMBL18733473 | 0.92 | HDAC1 (0.64) | ATMALDH1A1THRBCYP2C9CYP2C19 | |
| SCHEMBL28943620 | 0.90 | TACR1 (0.66) | ATMALDH1A1THRBCYP2C9CYP2C19 | |
| SCHEMBL11321133 | 0.89 | ATM (0.63) | ATMALDH1A1THRBCYP2C9CYP2C19 | |
| SCHEMBL16668525 | 0.89 | ALDH1A1 (0.62) | ATMALDH1A1THRBCYP2C9CYP2C19 | |
| SCHEMBL9020754 | 0.89 | ALDH1A1 (0.62) | ATMALDH1A1THRBCYP2C9CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 52 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0028251-B1 | PROCESS FOR PRODUCING N-ACYL-D-PHENYLALANINE ESTER | ETHYL CORPORATION (US) | 1983-03-16 | — | — | EP | claimed |
| EP-0028251-A1 | PROCESS FOR PRODUCING N-ACYL-D-PHENYLALANINE ESTER. | ETHYL CORP (US) | 1981-05-13 | — | — | EP | claimed |
| US-4262092-A | Process for producing N-acyl-D-phenylalanine ester | ETHYL CORPORATION (US) | 1981-04-14 | — | — | US | claimed |
| EP-0028251-A4 | PROCESS FOR PRODUCING N-ACYL-D-PHENYLALANINE ESTER. | ETHYL CORP (US) | 1981-03-27 | — | — | EP | claimed |
| WO-1980002421-A1 | PROCESS FOR PRODUCING N-ACYL-D-PHENYLALANINE ESTER | ETHYL CORP (US) | 1980-11-13 | — | — | WO | claimed |
| CN-114573473-B | Preparation method of (R) -alpha-aryl alanine ester derivative | 浙江工业大学 | 2023-11-28 | — | — | CN | disclosed |
| CN-114573473-A | Preparation method of (R) -alpha-aryl alanine ester derivative | 浙江工业大学 | 2022-06-03 | — | — | CN | disclosed |
| US-11325875-B2 | Compound having chiral spirobiindane skeleton and preparation method therefor | ZHEJIANG JIUZHOU PHARM CO LTD (CN) | 2022-05-10 | — | — | US | disclosed |
| EP-1451133-B1 | P-CHIRAL PHOSPHOLANES AND PHOSPHOCYCLIC COMPOUNDS AND THEIR USE IN ASYMMETRIC CATALYTIC REACTIONS | PENN STATE RES FOUND (US) | 2017-10-25 | — | — | EP | disclosed |
| EP-1451133-B1 | P-CHIRAL PHOSPHOLANES AND PHOSPHOCYCLIC COMPOUNDS AND THEIR USE IN ASYMMETRIC CATALYTIC REACTIONS | PENN STATE RES FOUND (US) | 2017-10-25 | — | — | EP | disclosed |
| WO-2017107789-A1 | COMPOUND HAVING CHIRAL SPIROBIINDANE SKELETON AND PREPARATION METHOD THEREFOR | 浙江九洲药业股份有限公司 | 2017-06-29 | — | — | WO | disclosed |
| US-9029571-B2 | Device and method for evaluating organic material for organic solar cell | NIPPON CHEMICAL INDUSTRIAL CO., LTD. (JP) | 2015-05-12 | — | — | US | disclosed |
| EP-0028251-B1 | PROCESS FOR PRODUCING N-ACYL-D-PHENYLALANINE ESTER | ETHYL CORPORATION (US) | 1983-03-16 | — | — | EP | disclosed |
| EP-0028251-A1 | PROCESS FOR PRODUCING N-ACYL-D-PHENYLALANINE ESTER. | ETHYL CORP (US) | 1981-05-13 | — | — | EP | disclosed |
| EP-0028251-A1 | PROCESS FOR PRODUCING N-ACYL-D-PHENYLALANINE ESTER. | ETHYL CORP (US) | 1981-05-13 | — | — | EP | disclosed |
| US-4262092-A | Process for producing N-acyl-D-phenylalanine ester | ETHYL CORPORATION (US) | 1981-04-14 | — | — | US | disclosed |
| EP-0028251-A4 | PROCESS FOR PRODUCING N-ACYL-D-PHENYLALANINE ESTER. | ETHYL CORP (US) | 1981-03-27 | — | — | EP | disclosed |
| EP-0028251-A4 | PROCESS FOR PRODUCING N-ACYL-D-PHENYLALANINE ESTER. | ETHYL CORP (US) | 1981-03-27 | — | — | EP | disclosed |
| WO-1980002421-A1 | PROCESS FOR PRODUCING N-ACYL-D-PHENYLALANINE ESTER | ETHYL CORP (US) | 1980-11-13 | — | — | WO | disclosed |
| WO-1980002421-A1 | PROCESS FOR PRODUCING N-ACYL-D-PHENYLALANINE ESTER | ETHYL CORP (US) | 1980-11-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11325875-B2 | Compound having chiral spirobiindane skeleton and preparation method therefor | REN, VKORC1, NR3C2 | ATM 3703/4885ALDH1A1 106/4885THRB 1272/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.